WHX Labs Dubai is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Informa

WHX Labs Dubai

Molecular Diagnostics

Theme: Molecular Innovations: Transforming laboratory medicine and patient outcomes

12 February 2026

This specialised track features expert-led sessions covering next-generation sequencing implementation, rapid molecular testing for infectious diseases, advances in oncology biomarkers, quality assurance frameworks, and emerging technologies including CRISPR diagnostics and AI integration. Designed for molecular technologists, laboratory directors, and pathologists, the program addresses real-world challenges in assay validation, bioinformatics workflows, regulatory compliance, and clinical interpretation of complex molecular data. Participants will gain actionable insights to enhance laboratory operations, improve diagnostic accuracy, and implement innovative molecular approaches.
Chair
Dr Imran Mirza
Dr Imran Mirza
Consultant,
Anatomical and Clinical Pathology, Chair, Clinical Pathology, National Reference Laboratory, Abu Dhabi, UAE
  • Molecular detection of regional genetic disorders
  • Advanced molecular techniques for infectious disease surveillance
  • Oncology biomarker testing protocols
  • Pharmacogenomic testing implementation
  • Laboratory bioinformatics and data management
  • Focus on lab workflow and interpretation of molecular data
  • Interactive quiz format session
  • Presentation of papers/abstracts
WHX Labs Dubai
Be part of conference(s)